Willard Lew

5.7k citations

31 papers · 2.4k indexed · 1 hit paper · h-index 18

Epidemiology top 2%
- Influenza Virus Research Studies 12
Organic Chemistry top 2%
- Carbohydrate Chemistry and Synthesis 8
- Synthesis and Biological Evaluation 4
Molecular Biology top 10%
- Chemical Synthesis and Analysis 9
- Glycosylation and Glycoproteins Research 3
Computational Theory and Mathematics top 5%
Immunology top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Spectroscopy
- Analytical Chemistry and Chromatography 3
Cardiology and Cardiovascular Medicine
- Cardiac electrophysiology and arrhythmias 3

Co-authors: Dirk B. Mendel Choung U. Kim Matthew A. Williams Lijun Zhang W.G. Laver Raymond C. Stevens Norbert Bischofberger Ming S. Chen
Cited by: Epidemiology Organic Chemistry Molecular Biology
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Tetrahedron Letters (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Willard Lew

30 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Willard Lew

Since Specialization

Citations

This map shows the geographic impact of Willard Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willard Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willard Lew more than expected).

Fields of papers citing papers by Willard Lew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willard Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willard Lew. The network helps show where Willard Lew may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Willard Lew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Willard Lew Line = papers co-authored together Willard Lew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry Pharmaceuticals ·Xiaosuo Wang,Willard Lew,L ‘Héritier,Nan Zhang,Zohaib Hassan Zain,Yen-Ting Chen,Zhu Hua-liang,Paul Bonnitcha,David Sullivan,Wenpeng Zhang,Yuzhong Zheng,John O’Sullivan	2025	0
2	Process Development and Scale-Up of a Protease Inhibitor for the Treatment of HIV Featuring the Preparation of a Neopentyl Grignard Reagent and Development of a One-Pot Curtius Reaction Organic Process Research & Development ·敏男高田,Susan D. Rymer,Dietrich Steinhuebel,Christina Croteau,Darryl D. Dixon,Ma del Pilar Godoy-Caballero,B E Nutter,Willard Lew,Arthur L. Caplan,Sean Neville,M. F. Karim,Bing Shi,Jonathan C. Tripp,Jérémie J. M. Marlhens	2022	1
3	A Practical Synthesis of 1-N-SEM-Protected 3-Iodo-7-methyl-2-piperidin-3-ylindole Synthesis ·James G. Phillips,Maria Jaworska,Willard Lew	2009	1
4	Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Emily J. Hanan,Raymond V. Fucini,M.J. Romanowski,R.A. Elling,Willard Lew,Hans E. Purkey,Erica C. VanderPorten,Wenjin Yang	2008	22
5	Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Raymond V. Fucini,Emily J. Hanan,M.J. Romanowski,R.A. Elling,Willard Lew,Kenneth J. Barr,Jiang Zhu,Г.В. Максимов,Yang Liu,Bruce J. Fahr,Weon Dae Cho,Wilhelm Müller,IRAN FERREIRA DE MELO,Ingrid Choong,Erica C. VanderPorten,Minna Bui,Hans E. Purkey,Marc Evanchik,Wenjin Yang	2008	30
6	Identification of potent and novel small-Molecule inhibitors of caspase-3 Bioorganic & Medicinal Chemistry Letters ·Darin A. Allen,IRAN FERREIRA DE MELO,Ingrid Choong,Bruce J. Fahr,Matthew Burdett,Willard Lew,Warren L. DeLano,Eric M. Gordon,Joni W. Lam,Thomas O’Brien,Dennis Lee	2003	18
7	Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design Journal of Medicinal Chemistry ·Ingrid Choong,Willard Lew,Dennis Lee,IRAN FERREIRA DE MELO,Matthew Burdett,Joni W. Lam,Christian Wiesmann,Tinh N. Luong,Bruce J. Fahr,Warren L. DeLano,Robert S. McDowell,Darin A. Allen,Daniel A. Erlanson,Eric M. Gordon,Thomas O’Brien	2002	83
8	Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor Current Medicinal Chemistry ·Willard Lew,Xiao‐Wu Chen,Clayton Edward Powers	2000	191
9	Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity Bioorganic & Medicinal Chemistry Letters ·Willard Lew,Huiwei Wu,Xiaowu Chen,Bradford Graves,Paul A. Escarpe,Holly L. MacArthur,Dirk B. Mendel,Choung U. Kim	2000	21
10	Metabolism of the Influenza Neuraminidase Inhibitor Prodrug Oseltamivir in the Rat Drug Metabolism and Disposition ·David J. Sweeny,Guo Ying Wu,S. Al Faraj,Willard Lew,Keyu Wang,Kenneth C. Cundy	2000	33
11	Stereospecific synthesis of a GS 4104 metabolite: Determination of absolute sterochemistry and influenza neuraminidase inhibitory activity Bioorganic & Medicinal Chemistry Letters ·Willard Lew,Paul A. Escarpe,Dirk B. Mendel,David J. Sweeny,Choung U. Kim	1999	7
12	A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity Bioorganic & Medicinal Chemistry Letters ·Willard Lew,Huiwei Wu,Dirk B. Mendel,Paul A. Escarpe,Xiaowu Chen,W.G. Laver,Bradford Graves,Choung U. Kim	1998	27
13	Structure−Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors Journal of Medicinal Chemistry ·Choung U. Kim,Willard Lew,Matthew A. Williams,Huiwei Wu,Lijun Zhang,Xiaowu Chen,Paul A. Escarpe,Dirk B. Mendel,W.G. Laver,Raymond C. Stevens	1998	236
14	Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071 Antimicrobial Agents and Chemotherapy ·Rosalia Rachma Dihadiani,Paul A. Escarpe,Robert W. Sidwell,Matthew A. Williams,Willard Lew,Huiwei Wu,Choung U. Kim,Dirk B. Mendel	1998	126
15	Efficacy of GS 4104 in ferrets infected with influenza A virus Antiviral Research ·David Lowry-Duda,N. Bischofberger,Antonio Henrique Barroso Do Vale Filho,Willard Lew,James Merson,C. Sweet	1997	4
16	Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activitybreakdown → Journal of the American Chemical Society ·Choung U. Kim,Willard Lew,Matthew A. Williams,Hongtao Liu,Lijun Zhang,S. Swaminathan,Norbert Bischofberger,Ming S. Chen,Dirk B. Mendel,Rosalia Rachma Dihadiani,W.G. Laver,Raymond C. Stevens	1997	876
17	ChemInform Abstract: C3‐Thia and C3‐Carba Isosteres of a Carbocyclic Influenza Neuraminidase Inhibitor, (3R,4R,5S)‐4‐Acetamido‐5‐amino‐3‐propoxy‐1‐ cyclohexene‐1‐carboxylic Acid. ChemInform ·Willard Lew,Matthew A. Williams,Dirk B. Mendel,Paul A. Escarpe,薛允猷	1997	1
18	Palladium-Promoted Synthesis of Ionophore Antibiotics. Strategy and Assembly of the Homochiral Tetrahydrofuran and Tetrahydropyran Portions of Tetronomycin Journal of the American Chemical Society ·M. F. SEMMELHACK,W. R. Epa,Domas Lavrukaitis,Y Gu,A Nowowiejska,Guorui Hou,Willard Lew	1994	26
19	Efficient total synthesis of the cytotoxic halogenated monoterpene aplysiapyranoid A Tetrahedron Letters ·Michael E. Jung,Derin C. D’Amico,Willard Lew	1993	11
20	Es route to polyene macrolide total synthesis; The key chiral segments of roflamycoin Tetrahedron Letters ·Bruce H. Lipshutz,Hiyoshizo Kotsuki,Willard Lew	1986	22

About Willard Lew

Willard Lew is a scholar working on Organic Chemistry, Biochemistry, Epidemiology, Toxicology and Molecular Biology, having authored 31 papers that have together received 2.4k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (12 papers), Chemical Synthesis and Analysis (9 papers), Carbohydrate Chemistry and Synthesis (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Synthesis and Biological Evaluation (4 papers), Glycosylation and Glycoproteins Research (3 papers), Analytical Chemistry and Chromatography (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Epidemiology (1.3k citations), Organic Chemistry (886 citations), Molecular Biology (1.2k citations), Computational Theory and Mathematics (189 citations) and Immunology (236 citations). Willard Lew has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Dirk B. Mendel, Choung U. Kim, Matthew A. Williams, Lijun Zhang, W.G. Laver, Raymond C. Stevens, Norbert Bischofberger, Ming S. Chen, Paul A. Escarpe and S. Swaminathan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Antimicrobial Agents and Chemotherapy, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact